But Trump and the GOP-controlled Senate gave up some of the leverage the U.S. might have had at the WHO by failing to confirm a delegate to the executive board. Executive board seats last for three-year terms, with representatives required to be “technically qualified in the field of health.” The U.S.’ latest term on the board, the WHO’s equivalent of the United Nations Security Council, started in 2018 after a required year off in 2017.
But the last Senate-confirmed U.S. representative on the WHO’s executive board was then-Centers for Disease Control Director Tom Frieden, whose term expired around the time Obama left office.
It wasn’t until 10 months after the United States’ current term began in 2018 when Trump nominated Admiral Brett Giroir, the assistant secretary for health at the Department of Health and Human Services, for the job.
Giroir, a four-star admiral in the U.S. Public Health Service Commissioned Corps, is a medical doctor with a background in infectious diseases who has previously worked on pandemic response. He's a well-qualified and relatively uncontroversial pick by Trump standards. And while Democrats have raised
concerns about his views on reproductive issues, he was confirmed by the Senate for his current role at HHS by a voice vote and has met with little Democratic resistance for this nomination.
But since his initial nomination, the White House, Senate Majority Leader Mitch McConnell (R-Ky.), and the rest of the Senate Republican leadership have shown no urgency about filling the appointment.